Skip to main content

Advertisement

SpringerLink
Log in

Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR)

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Soria JC, Ohe Y, Vansteenkiste J, et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med. 2018;378(2):113–25.

    Article  CAS  Google Scholar 

  2. Wu YL, Tsuboi M, He J, et al. Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med. 2020;383(18):1711–23.

    Article  CAS  Google Scholar 

  3. Iyengar P, Wardak Z, Gerber DE, et al. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol. 2018;4(1):e173501.

    Article  Google Scholar 

  4. Gomez DR, Tang C, Zhang J, et al. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol. 2019;37(18):1558–65.

    Article  CAS  Google Scholar 

  5. Coster JN, Groth SS. Surgery for locally advanced and oligometastatic non-small cell lung cancer. Surg Oncol Clin N Am. 2020;29(4):543–54.

    Article  Google Scholar 

  6. Ohtaki Y, Shimizu K, Suzuki H, et al. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment. Lung Cancer. 2021;153:108–16.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Tahsin M. Khan MD, Emily A. Verbus MD & Jonathan M. Hernandez MD

  2. Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Saumil Gandhi MD, PhD

  3. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Medical Center, Houston, TX, USA

    John V. Heymach MD, PhD & Yasir Y. Elamin MD

Authors
  1. Tahsin M. Khan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emily A. Verbus MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saumil Gandhi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John V. Heymach MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasir Y. Elamin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jonathan M. Hernandez MD or Yasir Y. Elamin MD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 161 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, T.M., Verbus, E.A., Gandhi, S. et al. Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR). Ann Surg Oncol 29, 4688–4689 (2022). https://doi.org/10.1245/s10434-022-11627-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11627-9

Search

Navigation